Loading Events

BE Seminar – Rylie Green, “Living Biolectrics: Polymer Materials Enabling Adaptive Neural Interfaces and Electroceutical Therapies”

February 19 at 3:30 PM - 4:30 PM
Details
Date: February 19, 2026
Time: 3:30 PM - 4:30 PM
  • Event Tags:
  • Organizer
    Bioengineering
    Phone: 215-898-8501
    Venue
    Berger Auditorium (Room 13), Skirkanich Hall 210 South 33rd Street
    Philadelphia
    PA 19104
    Google Map

    Professor Rylie Green is the Sir Leon Bagrit Chair in Bioengineering at Imperial College London. Her research focuses on polymer bioelectronics and regenerative neural interfaces, with the goal of developing materials and devices that enable seamless communication between electronic systems and the nervous system.

    Her group develops electroactive polymer biomaterials, biohybrid neural interfaces, and fully polymeric implantable and wearable bioelectronic devices designed to improve device stability, biological integration, and therapeutic capability. She is particularly known for pioneering “living bioelectronics,” a framework that integrates biological cells with electroactive materials to create adaptive neural interfaces capable of recording, stimulation, and therapeutic delivery.

    Professor Green works closely with neurosurgeons and reconstructive microsurgeons through clinical collaborations across Imperial College Healthcare NHS Trust, partner hospitals across the UK National Health Service, and international clinical collaborators including surgical teams in the United States. Her research spans neural prosthetics, regenerative neurotechnology, wearable neurophysiological monitoring, and electroceutical drug delivery platforms.

    Her work has generated over 200 publications, patents, and translational technologies, including devices advancing toward clinical application through academic–industry partnerships and the biomedical spinout Polymer Bionics Ltd. She also collaborates with industry and government partners, including advisory and research partnerships with neurotechnology companies and U.S. federal agencies supporting advanced bioelectronic medicine and neuroengineering initiatives.